Who is sponsoring NCT07455799?

NCT07455799 is sponsored by Assiut University.

What drugs are being tested in NCT07455799?

Interventions in NCT07455799: Electrocardiography (ECG) and Echocardiography (ECHO).

What condition does NCT07455799 study?

NCT07455799 studies End Stage Renal Failure, Hemodialysis.

Is NCT07455799 still recruiting?

NCT07455799 is currently not yet recruiting. Last updated 16 March 2026.

Last reviewed 2026-03-16 · How we verify

NCT07455799

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Missed Dialysis Sessions on Short Term Cardiovascular Events

Not yet recruiting Last updated 16 March 2026

What this trial tests

trial testing Electrocardiography (ECG) and Echocardiography (ECHO) in End Stage Renal Failure, Hemodialysis in 225 participants. Not yet recruiting.

Timeline

1 October 2026

Primary endpoint
1 October 2027

1 December 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	225
Start date	1 October 2026
Primary completion	1 October 2027
Estimated completion	1 December 2027
Sites	1 location across Egypt

Drugs / interventions tested

Electrocardiography (ECG) and Echocardiography (ECHO)

Conditions studied

End Stage Renal Failure, Hemodialysis — all drugs for End Stage Renal Failure, Hemodialysis →

Sponsor

Assiut University

Who can join

Adults 18 to 85, any sex, with End Stage Renal Failure, Hemodialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the effect of missed hemodialysis sessions on the occurrence of short-term cardiovascular events in patients with end-stage renal disease receiving maintenance hemodialysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07455799 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 16 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07455799.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing